The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.
Metabolic Syndrome-Related Kidney Injury: A Review and Update
Open accessAbstract
Metabolic syndrome (MetS) includes visceral obesity, hyperglycemia, dyslipidemia, and hypertension. The prevalence of MetS is 20-25%, which is an important risk factor for chronic kidney disease (CKD). MetS causes effects on renal pathophysiology, including glomerular hyperfiltration, RAAS, microalbuminuria, profibrotic factors and podocyte injury. This review compares several criteria of MetS and analyzes their differences. MetS and the pathogenesis of CKD includes insulin resistance, obesity, dyslipidemia, inflammation, oxidative stress, and endothelial dysfunction. The intervention of MetS-related renal damage is the focus of this article and includes controlling body weight, hypertension, hyperglycemia, and hyperlipidemia, requiring all components to meet the criteria. In addition, interventions such as endoplasmic reticulum stress, oxidative stress, gut microbiota, body metabolism, appetite inhibition, podocyte apoptosis, and mesenchymal stem cells are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although the study was not designed to examine mechanism(s) underlying CVD risk reduction in CKM, cardioprotective properties of EPA that offset inflammation and oxidative stress while improving endothelial function may have been operative in this high-risk phenotype [[15], [16], [17], [18]].”
From Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM (2026) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647 · cited 1×
“Liraglutide is a widely used GLP-1 receptor agonist, which has definite efficacy in reducing plaque formation and antiatherosclerotic action (141).”
BackgroundMetabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,199
Moore, J. X., Chaudhary, N. S., & Akinyemiju, T. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160287 · Cited by 940
Research works printed but not linked: 1
- Alexander, 2009, Singh AK.Kidney Pathological Changes in Metabolic Syndrome: A Cross-Sectional Study, Am J Kidney Dis, 5, 10.1053/j.ajkd.2009.01.255 · DOI
Cited by
Sorted by citations
The Role of Inflammation in CKD
Kadatane, S., Satariano, M., Massey, M., Mongan, K., & Raina, R. (2023) · Cells · doi:10.3390/cells12121581 · Cited by 350
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Xie, K., Cao, H., Ling, S., Zhong, J., Chen, H., Chen, P., & Huang, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1526482 · Cited by 124
Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661603 · Cited by 117
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 86
Takić, M. M., Ranković, S., Girek, Z., Pavlović, S., Jovanović, P., Jovanović, V. B., & Šarac, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094909 · Cited by 75
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 67
Liang, H., & Song, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300705 · Cited by 36
Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Covic, A. S., & Covic, A. C. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.014 · Cited by 39
Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy
Ma, L., Liu, D., Yu, Y., Li, Z., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1587806 · Cited by 38
Kataoka, H., Nitta, K., & Hoshino, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1179834 · Cited by 32
Bilson, J., Hydes, T., McDonnell, D., Buchanan, R. M., Scorletti, E., Mantovani, A., Targher, G., & Byrne, C. D. (2024) · Liver International · doi:10.1111/liv.16159 · Cited by 27
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
Esposito, P. B., Picciotto, D., Cappadona, F., Costigliolo, F., Russo, E., Macciò, L., & Viazzi, F. C. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1450 · Cited by 23
Metabolic Syndrome, Kidney-Related Adiposity, and Kidney Microcirculation: Unraveling the Damage
Jang, K. W., Hur, J., Lee, D. W., & Kim, S. R. (2024) · Biomedicines · doi:10.3390/biomedicines12122706 · Cited by 24
A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population
Ho, C., Lee, J., Huang, S., Chen, S., & Geng, J. (2023) · Nutrients · doi:10.3390/nu16010077 · Cited by 23
Wang, Z., Zhou, Z., Zhao, Z., Zhang, J., Zhang, S., Li, L., Fan, Y., & Li, Q. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118029 · Cited by 19
López‐Baltanás, R., Rodríguez-Ortiz, M. E., Díaz‐Tocados, J. M., Martinez-Moreno, J. M., Membrives, C., Rodelo‐Haad, C., de Mier, M. V. P.-R., Rodríguez, M., Canalejo, A., Almadén, Y., et al. (2023) · Antioxidants · doi:10.3390/antiox12020283 · Cited by 19
Liu, Y., Wang, H., Geng, Y.-H., Han, L., Tu, S., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1112088 · Cited by 19
Arellano-Buendía, A. S., Juárez-Rojas, J. G., García‐Arroyo, F. E., Aparicio‐Trejo, O. E., Sánchez‐Muñoz, F., Argüello-García, R., Sánchez‐Lozada, L. G., Bojalil, R., & Osorio‐Alonso, H. (2023) · PeerJ · doi:10.7717/peerj.16132 · Cited by 19
Dyslipidemia-induced renal fibrosis related to ferroptosis and endoplasmic reticulum stress
Jiang, Y., Zhu, X., Jordan, K. L., Li, Y., Conley, S. M., Tang, H., Lerman, A., Eirin, A., Ou, T., & Lerman, L. O. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100610 · Cited by 18
Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys
Zbrzeźniak, J., Winiarska, A., Perkowska‐Ptasińska, A., & Stompór, T. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136247 · Cited by 20
He, Y., Tang, W., Chen, J., Tang, J., Zheng, Y., Wang, X., Xing, B., Li, X., Xu, Y., & Wang, X. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04386-8 · Cited by 19
Joubert, M. B. V., Ingaramo, P. I., Collins, P., & D’Alessandro, M. E. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109779 · Cited by 15
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor
Lin, L., Pan, X., Feng, Y., & Yang, J. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241252309 · Cited by 14
Self-citationKhalili, S., Safavi‐Naini, S. A. A., Zarand, P., Masoumi, S., Farsi, Y., Hosseinpanah, F., & Azizi, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-56061-x · Cited by 13
Merce, A.-G., Nisulescu, D. D., Hermenean, A. O., Burciu, O. M., Munteanu, I.-R., Merce, A.-P., Brie, D. M., & Mornoş, C. (2026) · Metabolites · doi:10.3390/metabo16010059 · Cited by 12
Exercise Testing for Metabolic Flexibility: Time for Protocol Standardization
Lovell, D. I., Stuelcken, M., & Eagles, A. N. (2025) · Sports Medicine - Open · doi:10.1186/s40798-025-00825-w · Cited by 14
Keyghobadi, H., bozorgpoursavadjani, H., Koohpeyma, F., Mohammadipoor, N., Nemati, M., Dehghani, F., Jamhiri, I., Keighobadi, G., & Dastghaib, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09542-1 · Cited by 10
Sun, J., Huang, B., Zhao, W., Li, Q., Yin, S., Zhang, Y., & Huang, R. (2025) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251353658 · Cited by 9
Gut microbiota-derived SCFAs and MetS-related nephropathy
Tian, X., Sun, L., Guo, S., Yuan, L., Zhang, T., Huang, C., He, T., Jiang, Q., & Zeng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561271 · Cited by 11
Zhu, L., Ruan, X., Wang, J., Yan, Y., Tang, C., & Xu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442274 · Cited by 8
Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma
Stepanova, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113678 · Cited by 11
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review
Hu, L., Borelli, G., Gessaroli, E., Ruotolo, C., Bin, S., Papalia, G., Patella, G., Liberti, M. E., Baraldi, O., Zaza, G., et al. (2025) · Life · doi:10.3390/life15060896 · Cited by 9
Metabolic disorder–associated kidney disease and diabetic kidney disease in developing countries
Bavanandan, S., Noronha, I. L., Tchokhonelidze, I., & Liew, A. (2025) · Kidney International · doi:10.1016/j.kint.2025.03.034 · Cited by 8
The Role of Comorbidities in COVID-19 Severity
König, S., Vaskyte, U., Boesing, M., Lüthi-Corridori, G., & Leuppi, J. D. (2025) · Viruses · doi:10.3390/v17070957 · Cited by 8
Liu, C., Yang, J., Li, H., Deng, Y., He, P., Zhang, J., & Zhang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1412823 · Cited by 7
Self-citationYang, H., Cui, Z., & Quan, Z. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0161 · Cited by 7
Metabolic syndrome–associated kidney disease in young adolescents and children
Raina, R., Hu, J., Chan, E. Y.-H., Hinton, J., & Mitsnefes, M. M. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.036 · Cited by 6
Sex differences in the progression of cardiovascular–kidney–metabolic syndrome
Taya, S., Ejiri, K., Kaneko, H., Suzuki, Y., Miyoshi, T., Mizuno, A., Ko, T., Jimba, T., Azegami, T., Okada, A., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf162 · Cited by 6
Associations between metabolic profiles and incident CKD in the Chinese population aged 45–85 years
Zhu, B., Shi, Y., Song, N., Zhao, S., Shen, B., Wang, J., Zhang, W., Lu, Y., Fang, Y., Ding, X., et al. (2024) · International Urology and Nephrology · doi:10.1007/s11255-023-03916-3 · Cited by 6
Tang, L., Wan, W., Zhang, J., Zhang, H., Wang, Y., & Li, X. (2024) · Shock · doi:10.1097/shk.0000000000002462 · Cited by 7
Czarnecka, K., Czarnecka, P., Tronina, O., Bączkowska, T., & Durlik, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061719 · Cited by 6
Yang, S., Ling, J., Zhang, S., Li, Y., & Yang, G. (2024) · The Aging Male · doi:10.1080/13685538.2024.2335158 · Cited by 6
Neumann, C., Schneider, F., Hilfenhaus, G., Vecchione, L., Benzing, C., Ihlow, J., Fehrenbach, U., Malinka, T., Keilholz, U., Stintzing, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113656 · Cited by 6
Multi‐target Drugs to Treat Metabolic Diseases
Lillich, F. F., Goorani, S., Proschak, E., & Imig, J. D. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch13 · Cited by 6
Peng, H., Ren, J., Zhao, Y., Fang, X., Wang, X., Liu, C., & Wan, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112235 · Cited by 7
Marshall, W. R., Green, D., Sinha, S., & Kalra, P. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1785937 · Cited by 5
Akune, Y., Anezaki, H., Nakao, Y. M., & Goto, R. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-072688 · Cited by 5
Bai, J., Zhang, L., He, L., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1613640 · Cited by 6
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Lian, K., Zhang, K., Kan, C., Hou, N., Han, F., Sun, X., Qiu, H., & Guo, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122801 · Cited by 5
Enhancing Metabolic Syndrome Detection through Blood Tests Using Advanced Machine Learning
Paplomatas, P., Rigas, D., Sergounioti, A., & Vrahatis, A. G. (2024) · Eng—Advances in Engineering · doi:10.3390/eng5030075 · Cited by 4
Liang, N., Ma, X., Cao, Y., Liu, T., Fang, J., & Zhang, X. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303288685240808073238 · Cited by 5
Ruiz‐García, A., Arranz-Martínez, E., Serrano-Cumplido, A., Cinza‐Sanjurjo, S., Escobar, C., García, J. P., & Pallarés‐Carratalá, V. (2025) · Biomedicines · doi:10.3390/biomedicines13030590 · Cited by 4
Kabootari, M., Tirtashi, R. H., Amouzegar, A., Masoumi, S., Azizi, F., & Amouzegar, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-03690-5 · Cited by 4
Differential Proneness to Obesity in Two Rat Strains with Diverse Immune Responses
Tucović, D., Aleksandrov, A. P., Popović, D., Malešević, A., Subota, V., Brdarić, E., Bajić, S. S., Živković, M., Kataranovski, M. V., Mirkov, I. I., et al. (2025) · Biology · doi:10.3390/biology14050557 · Cited by 3
Zhang, F., & Li, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s516687 · Cited by 3
Wang, Y., & Li, S. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2420841 · Cited by 3
Lin, X., & Yang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409560 · Cited by 3
Rodríguez-Mortera, R., Torres, P., Fernàndez‐Bernal, A., Berdún, R., Ramírez‐Núñez, O., Martin‐Garí, M., Serrano, J. C. E., He, C., Prat, J., Pamplona, R., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.030 · Cited by 3
Huang, Y., Fu, R., Zhang, J., Zhou, J., Chen, S., Lin, Z., Xie, X., & Hu, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01958-5 · Cited by 3
Kotb, E., mancy, I. M. E., Mohamed, I. G. R., Ayoub, H. S. A., Rashed, A.-S. M., EL-Nasser, W. S., Hamed, H. I., Aladl, H. A. A., Sabrh, M. A. M., Eliwa, A., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231171405 · Cited by 3
Renal damage in Hepatorenal Syndrome: A still unsolved issue
Calleri, A., & Alessandria, C. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102178 · Cited by 3
Tang, Y., Zhou, Q., Zhao, N., Niu, F., Li, S., Zuo, Y., Huang, J., Wang, Z., Han, T., & Wei, W. (2024) · Food & Function · doi:10.1039/d4fo02777a · Cited by 4
Quetglas‐Llabrés, M. M., Díaz‐López, A., Bouzas, C., Monserrat-Mesquida, M., Salas‐Salvadó, J., Ruiz‐Canela, M., Martínez, J. A., Santos‐Lozano, J. M., García, S., Estruch, R., et al. (2025) · Antioxidants · doi:10.3390/antiox14080975 · Cited by 2
Exploring the link between selective glomerular filtration and intima media thickness
Lundbergs, R., Annell, N. B., Kennbäck, C., Jujić, A., Holm, H., Christensson, A. G., & Laučytė-Cibulskienė, A. (2025) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2025.2585472 · Cited by 2
Du, Y., & Wang, K. (2025) · Rejuvenation Research · doi:10.1177/15491684251399607 · Cited by 3
Liang, H., Liu, Z., Zhao, N., Lei, S., Zhu, S., & Ma, J. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s583563 · Cited by 2
Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee
Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3
Li, Z., Fu, C. Y., Sun, C., Suo, Y., Li, K., & Qi, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31180 · Cited by 2
Wang, Y., Chen, M., Wang, L., & Wu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1400577 · Cited by 2
Zhou, Z., Wang, Y., Xing, Y., Pan, S., Wang, W., Yang, J., Wu, W., Zhou, J., Huang, L., Liang, Q., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17111416 · Cited by 2
Self-citationDube, L., Mills, N. T., Le, T. D., Hyppönen, E., & Lee, S. (2025) · Human Genetics · doi:10.1007/s00439-025-02762-w · Cited by 2
Effects of Cherry Consumption on Metabolic Health: A Pilot Clinical Study on Healthy Adults
Carvalho, F., Varges, A., Lahlou, R. A., Bárbara, E. M. P., Santos, I., Fonseca, C., & Silva, L. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188891 · Cited by 3
Feng, X., Xuan, R., Dong, Y., Wu, X., Cheng, Y., Yuan, Z., Dong, H., Han, J., Zhong, F., Zhao, J., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030488 · Cited by 2
Periconceptional Serum Creatinine and Risk of Childhood Autism Spectrum Disorder: A Research Letter
Harel, Z., Jeyakumar, N., Kang, Y., Vélez, M. P., Dayan, N., & Ray, J. G. (2023) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581231221892 · Cited by 1
Jeon, J., Lee, K., Jeon, H., Yang, K. E., Lee, C., Lee, J. E., Kwon, G. Y., Huh, W., & Jang, H. R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1494660 · Cited by 1
Zhao, X., Wang, Z., Xia, Z., Chen, H., Zhu, Y., Wang, S., Bao, Y., Liu, Y., Wang, H., & Ao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02346-1 · Cited by 1
Zhou, L., Yu, J., Cai, X., Zhu, Y. M., Li, M., Han, X., & Ji, L. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02014-y · Cited by 4
Ousmaal, M. E. F., Gaceb, A., Benali, A., & Giaimis, J. (2025) · Ultrastructural Pathology · doi:10.1080/01913123.2025.2575988 · Cited by 1
Li, S., Chen, Y.-J., Mei, Y., Mo, X., Chen, J., Li, C., Chen, X., Han, D. H., Li, Y., & Zhang, X. (2025) · Journal of International Medical Research · doi:10.1177/03000605251399039 · Cited by 1
Chagas, C. A. A., Pires, L. A. S., Rodriguez, B. C., Ribeiro, B. F. D. S., Fonseca, A., & Babinski, M. A. (2026) · Medicina · doi:10.3390/medicina62010219 · Cited by 1
The Vicious Cycle of Diabetic Kidney Disease, Vitamin D Deficiency, and Arterial Hypertension
Kurzyna, B., Czebreszuk, P., Szczerbińska, W., Michalak, B., Walędziak, M., & Różańska-Walędziak, A. M. (2026) · Healthcare · doi:10.3390/healthcare14050662 · Cited by 1
Ouyang, Z., Hu, W., Zhu, F., Zhang, Y., Wang, L., & Ye, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1854704 · Cited by 1
Witkowski, M., Przybyciński, J., Wojciuk, B., Czaja, W., Gołembiewska, N., & Gołembiewska, E. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.16436 · Cited by 1
Fuentes-Barría, H., Aguilera-Eguía, R. A., Alarcón-Rivera, M., & Flores-Fernández, C. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080850 · Cited by 1
Energy Dynamics in the Metabolic Syndrome: Underpinnings of an Evolving Global Catastrophe
Thorp, K. E., Thorp, E. M., & BS, F. W. (2024) · The Gazette of Medical Sciences · doi:10.46766/thegms.endocrinol.24051901
Escobar‐Domingo, M. J., Alvarez, A. H., Merle, C., Fanning, J. E., Lee, D., Foppiani, J., Kim, E., Lin, S. J., & Lee, B. T. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.05.046 · Cited by 1
Yang, L., Li, L., Zeng, T., Li, Y., Li, Y., Jiang, D., & Yue, H. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03557-5 · Cited by 1
Kim, H. (2023) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e3 · Cited by 1
Metabolic Syndrome and Kidney Diseases
Boima, V., Agyekum, A. B., & Eduafo, A. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_57 · Cited by 2
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
Miller, M., Bhatt, D. L., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Pineda, A. L., Tardif, J.-C., & Ballantyne, C. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101387
dos Santos, G. M., Nunes, I. F. D. O. C., de Oliveira, F. E., Nogueira, T. R., Sousa, P. V. D. L., Primo, M. G. S., da Paz, S. M. R. S., & de Carvalho, C. M. R. G. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401319666221216101853
Функція нирок у чоловіків із метаболічним синдромом
Luchytskyi, V. Y., Luchytskyi, Y. V., Zubkova, G., Rybalchenko, V. M., & Skladanna, I. I. (2022) · Endokrynologia · doi:10.31793/1680-1466.2022.27-3.251
Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology
Zakharova, E., & Vorobyeva, O. A. (2023) · Kidney and Dialysis · doi:10.3390/kidneydial3020015
Is Subcutaneous Rifamycin Application Superior to Saline Application in Hip Hemiarthroplasty?
Çelik, M., Ziroğlu, N., & Bayrak, A. (2023) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.4274/bmj.galenos.2023.2022.4-19
Relationship between serum vitamin d levels and the risk of developing metabolic syndrome
López-Chango, V. A., & Pérez, E. A. G. (2023) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt2023433
Research Progress of FGF-21 and CVAI in Type 2 Diabetic Kidney Disease
才巴, 央. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371690
Metabolic Syndrome and Kidney Diseases
Boima, V., Agyekum, A. B., & Eduafo, A. K. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_57-1
Potential Reno-protective Influence of Canagliflozin in Male Albino Rats with Metabolic Syndrome
Shamardl, H. A., Sadek, S. A., & Ahmed, A. (2023) · Fayoum University Medical Journal/Fayoum University Medical Journal · doi:10.21608/fumj.2023.323609
Study of The Relation Between Thyroid Function and Metabolic Syndrome in Elderly Patients
Elshourbagy, E., Hassaan, M., Mohamed, S., & Allam, A. A. (2024) · Zagazig University Medical Journal · doi:10.21608/zumj.2024.272004.3187
Metadata
- Authors
- Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., & Yang, J.
- Affiliations
- Chongqing Medical University (CN)
- People's Hospital of Kaizhou District (CN)
- Corresponding author
- Yang, Jurong
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-23
- Volume
- 13
- Pages
- 904001-904001
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC9261267
- OpenAlex
- W4283317650
- Cited by
- 139
- References
- 162
- Citations by year
- 2026: 27 · 2025: 51 · 2024: 37 · 2023: 22 · 2022: 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- metabolic syndrome, chronic kidney disease, kidney injury, visceral obesity, hyperglycemia, dyslipidemia, hypertension, glomerular hyperfiltration, renin-angiotensin-aldosterone system, microalbuminuria, podocyte injury, renal fibrosis, insulin resistance, oxidative stress, endothelial dysfunction, endoplasmic reticulum stress, gut microbiota, mesenchymal stem cells, podocyte apoptosis
- MeSH terms
- Humans, Hyperglycemia, Hypertension, Kidney, Metabolic Syndrome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
